[go: up one dir, main page]

KR910000180A - 트롬빈 억제 활성을 갖는 폴리펩티드 및 그의 제조방법 - Google Patents

트롬빈 억제 활성을 갖는 폴리펩티드 및 그의 제조방법 Download PDF

Info

Publication number
KR910000180A
KR910000180A KR1019900008461A KR900008461A KR910000180A KR 910000180 A KR910000180 A KR 910000180A KR 1019900008461 A KR1019900008461 A KR 1019900008461A KR 900008461 A KR900008461 A KR 900008461A KR 910000180 A KR910000180 A KR 910000180A
Authority
KR
South Korea
Prior art keywords
inhibitory activity
polypeptide
plasmid
thrombin inhibitory
secretory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019900008461A
Other languages
English (en)
Other versions
KR930003913B1 (ko
Inventor
요시오 후루따니
마사루 혼조오
아끼라 나까야마
고오이찌 가와무라
가즈노리 안도오
미찌꼬 호리
게이꼬 후까자와
Original Assignee
사와무라 하루오
미쓰이도오 아쓰가가꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사와무라 하루오, 미쓰이도오 아쓰가가꾸 가부시끼가이샤 filed Critical 사와무라 하루오
Publication of KR910000180A publication Critical patent/KR910000180A/ko
Application granted granted Critical
Publication of KR930003913B1 publication Critical patent/KR930003913B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B1/00—Engines characterised by fuel-air mixture compression
    • F02B1/02—Engines characterised by fuel-air mixture compression with positive ignition
    • F02B1/04—Engines characterised by fuel-air mixture compression with positive ignition with fuel-air mixture admission into cylinder

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

내용 없음

Description

트롬빈 억제 활성을 갖는 폴리펩티드 및 그의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 이종 단백질 발현 분비 백터, pNPA225를 제조하는 방법을 나타낸다.
제2도는 HV1형 히루딘 분비플라스마, pHph208를 제조하는 방법을 나타낸다.
제3도는 히루딘을 코딩하는 DNA서열을 함유하는 하이브리드 플라스미드 p3009를 제조하는 방법을 나타낸다.
제4도는 히루딘을 분비하는 플라스미드, pNPH141를 제조하는 방법을 나타낸다.

Claims (14)

  1. 하기 아미노산 서열을 갖는, 트롬빈 억제 활성을 갖는 폴리펩티드의 전구체,
  2. 하기 아미노산 서열을 갖는, 트롬빈 억제 활성을 갖는 폴리펩티드,
  3. 제1항에 기재된 트롬빈 억제 활성을 갖는 폴리펩티드의 전구체를 코딩하는 하기의 DNA 서열.
  4. 제2항에 기재된 트롬빈 억제 활성을 갖는 폴리펩티드의 전구체를 코딩하는 하기의 DNA 서열.
  5. (a)프로모터 영역 및 리보소옴 결합 부위를 코팅하는 영역을 함유하는 DNA서열, (b) DNA서열(a)의 3'말단에 결합 가능한, 제1항에 기재된 전구체를 코딩하는 DNA서열, 및 (c)숙주에서 복제가능한 벡터DNA를 함유하는 분비 플라스미드.
  6. 제5항에 있어서, DNA서열(a)내의 여역이 바실루스 아밀로리퀴파시엔스(Bacillus amyloliquifaciens)의 중성 프로테아제 유전자의 것이 분비 플라스미드.
  7. 제6항에 있어서, (a)와 (b)의 결합 DNA 서열이 하기와 같은 분비 플라스미드.
  8. 제5항 내지 제7항중 어느 한 항에 있어서, 벡터 DNA가 바실루스속의 세균에서 복제 가능한 플라스미드인 분비 플라스미드.
  9. 제8항에 있어서, 프라스미드가 pUB110인 분비 플라스미드.
  10. 제9항에 있어서, 분비 플라스미드가 pNPH141인 분비 플라스미드.
  11. 제5항 내지 제10항에 기재된 분비 플라스미드 중의 하나를 사용하여 형질 전환된 형질전환체.
  12. 제11항에 있어서, 형질전환된 미생물이 바실루스 서브틸리스 (Bacillus subtilis)인 형질전환체.
  13. 제12항에 있어서, 바실루스 서브틸리스가 바실루스 서브틸리스 FERM BP-2403인 형질전환체.
  14. 제12항 또는 제13항의 형질 전환체를 배양하고 배양 상충액으로부터 트롬빈 억제 활성을 갖는 폴리펩티드를 회수하는 단계를 특징으로 하는, 트롬빈 억제 활성을 갖는 폴리펩티드의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900008461A 1989-06-09 1990-06-09 트롬빈 억제 활성을 갖는 폴리펩티드 및 그의 제조방법 Expired - Fee Related KR930003913B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1145489A JP2859297B2 (ja) 1989-06-09 1989-06-09 トロンビン阻害活性を有するポリペプチドおよびその製造法
JP1-145489 1989-06-09
JP?1-145489 1989-06-09

Publications (2)

Publication Number Publication Date
KR910000180A true KR910000180A (ko) 1991-01-29
KR930003913B1 KR930003913B1 (ko) 1993-05-15

Family

ID=15386446

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900008461A Expired - Fee Related KR930003913B1 (ko) 1989-06-09 1990-06-09 트롬빈 억제 활성을 갖는 폴리펩티드 및 그의 제조방법

Country Status (6)

Country Link
US (1) US5166318A (ko)
EP (1) EP0402159B1 (ko)
JP (1) JP2859297B2 (ko)
KR (1) KR930003913B1 (ko)
CA (1) CA2018211C (ko)
DE (1) DE69013403T2 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624822A (en) * 1989-12-22 1997-04-29 Basf Aktiengesellschaft Hirudin fusion proteins and preparation of hirudin
EP0624642B1 (en) * 1993-05-12 1999-01-20 Indian Council For Medical Research Novel thrombolytic agent, process for preparing same and its use for the preparation of a thrombi dissolving medicament
CN115572329B (zh) * 2021-06-21 2024-02-06 王大勇 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151760A1 (en) * 1984-01-06 1985-08-21 Takeda Chemical Industries, Ltd. Novel DNA and use thereof
GB2171703B (en) * 1985-01-18 1989-11-15 Agency Ind Science Techn Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
FR2611723B1 (fr) * 1987-02-27 1989-09-08 Transgene Sa Vecteur d'expression d'adn recombinant codant pour l'hirudine, cultures de cellules de mammiferes infectees ou transformees, procede de preparation de l'hirudine et proteine obtenue

Also Published As

Publication number Publication date
EP0402159B1 (en) 1994-10-19
CA2018211A1 (en) 1990-12-09
DE69013403D1 (de) 1994-11-24
EP0402159A1 (en) 1990-12-12
KR930003913B1 (ko) 1993-05-15
DE69013403T2 (de) 1995-02-23
JP2859297B2 (ja) 1999-02-17
US5166318A (en) 1992-11-24
CA2018211C (en) 1996-02-20
AU5697090A (en) 1990-12-13
JPH0310694A (ja) 1991-01-18
AU620721B2 (en) 1992-02-20

Similar Documents

Publication Publication Date Title
O'Neill et al. Structure of the gene encoding the exoglucanase of Cellulomonas fimi
ES474852A1 (es) Un metodo para la expresion,en un huesped bacteriano trans- formado de un polipeptido heterologo con respecto al huespeden su estado no transformado
AU8822601A (en) Expression of biologically active polypeptides in duckweed
ATE80660T1 (de) Verfahren zur herstellung eines polypeptides.
EP0305488A4 (en) Mycobacterial recombinants and peptides
ES8605040A1 (es) Procedimiento para preparar un polipeptido con actividad de hirudina
ES2009238A6 (es) Metodo para producir proteinas de mycobacterium tuberculosis y peptidos antigenicos de las mismas.
KR830005350A (ko) 표면 결합체용 융합단백질 및 진핵 단백질 제조방법
WO1994018332A3 (en) Anthrax toxin fusion proteins and uses thereof
NZ216688A (en) Bacterial expression control sequences, plasmids and transformed host
PT83562B (pt) Processo para a expressao e secrecao de proteinas heterologas por transformantes de yarrowia lipolytica
IE883612L (en) Vectors and compounds for direct expression of activated human protein c
CS9100531A2 (en) Dna fragment that codes polypeptide with nitrile-hydratation activity,transformant that contains this gene and method of amides preparation with this transformant application
DE3686217D1 (de) Alkalische protease, verfahren zur herstellung von hybridvektoren und genetisch transformierte mikroorganismen.
KR920701425A (ko) 알칼리성 단백질 가수분해효소 및 그것의 제조방법
EP0150126A3 (en) The synthesis of protein with an identification peptide
EP0048970A3 (en) Polypeptides, process for their microbial production, intermediates therefor and compositions containing them
EP0196864A3 (en) Alkaline phosphatase-mediated processing and secretion of recombinant proteins, dna sequences for use therein and cells transformed using such sequences
ZA8860B (en) Pancreatic secretory trypsin inhibitor and variants thereof produced by a recombinant host,process,expression vector and recombinant host therefor and pharmaceutical use thereof
SE8204811D0 (sv) Dna fragment comprising a signal sequence
EP0133756A2 (en) Vector for expression of polypeptides
KR910000180A (ko) 트롬빈 억제 활성을 갖는 폴리펩티드 및 그의 제조방법
Le et al. Purification of secreted recombinant proteins from Escherichia coli
EP0195285A3 (en) Molecular cloning of the delta-endotoxin gene of bacillus thurigiensis var. israelensis
JPH02150285A (ja) バシルス・コアグランスのアミラーゼ遺伝子に基づくバシルス発現ベクター

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

FPAY Annual fee payment

Payment date: 20010510

Year of fee payment: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20020516

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20020516

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000